NewsRoom Articles - Page 131 of 222

ThursdayFeb 17, 2022 9:30 am

Study Finds That Asthma May Reduce Risk of Brain Tumor Development

A new study has found that asthma causes T lymphocyte cells in the body to induce inflammation of the lungs and also prevent the growth of brain tumors. T lymphocyte cells, or T cells, are a type of immune cells that become activated when an individual develops asthma, a breathing disease which causes their airways to become inflamed and narrow. The study was conducted by researchers from the School of Medicine at Washington University in St. Louis, whose objective was to find out whether individuals with asthma were less likely to develop brain tumors in comparison to other people. The…

WednesdayFeb 16, 2022 9:30 am

Study Finds That Quitting Smoking Is Harder for Women

A recently published study has found that women may find it harder to stop smoking in comparison to men, especially on the first day after quitting. The study was conducted by researchers at the Mailman School of Public Health, Columbia University, and its findings were published in the “Addictive Behaviors” journal. In a press release, João Mauricio Castaldelli-Maia, the first author of the study, stated that a successful first day of abstinence was an important predictor for long-term success when it came to smoking cessation, noting that not much was known about why women found this period more challenging in…

TuesdayFeb 15, 2022 9:30 am

Study Finds That Children Who Consume More Vegetables, Fruits Have Better Mental Health

A new study has found that children who consumed a diet full of vegetables and fruits had better mental well-being. The study, which was conducted by researchers from the University of East Anglia, is the first to look into the link between mental well-being, vegetable and fruit intake, breakfast and lunch choices in school children in the United Kingdom. The research was led by Social Care Partners and UEA Health, in partnership with Norfolk County Council. For the study, the team of researchers analyzed data obtained from more than 8,000 children in 50 schools across the county. Of this number,…

TuesdayFeb 15, 2022 9:30 am

Identified Psilocybin and MDMA Supplier, New Addition Strengthens Mydecine Innovations Group Inc.’s (NEO: MYCO) (OTC: MYCOF) Board Experience

Biotechnology company Mydecine Innovations Group is devoted to advancing the use of psychedelics for the treatment of mental illnesses and addiction Mydecine has necessary license to provide psilocybin and MDMA under Canada’s SAP program, which allows medical providers to request otherwise unavailable drug substances for the treatment of patients who have not seen success with available treatment options The license allows Mydecine to provide psilocybin and MDMA (Ecstasy) through its licensed Alberta facility and collaboration with non-profit drug development institute Applied Pharmaceutical Innovation The company has named pharmaceutical scientist and entrepreneur Dr. Victoria Hale to its Board of Directors, strengthening…

MondayFeb 14, 2022 9:30 am

UK Study Shows Dementia Risk Doubles for People with More Than One Chronic Disease

Dementia is a debilitating condition that affects individuals in their old age. The disease impacts around 57 million people globally, with experts predicting that by 2050, about 153 million individuals will have developed dementia. To compound matters even more, a new study has found that the risk of a middle-aged individual developing dementia heightens significantly, especially if they suffer from two or more chronic health issues in middle age. This is known as multimorbidity, which is the presence of two or more chronic diseases from a list of 13 diseases, including cancer, arthritis, liver disease, depression, stroke, heart failure, diabetes…

MondayFeb 14, 2022 9:30 am

Nemaura Medical Inc.’s (NASDAQ: NMRD) CEO Dr. Faz Chowdhury Addresses Growing CGM Demand at H.C. Wainwright BioConnect Conference

NMRD CEO Dr. Faz Chowdhury presented at H.C. Wainwright BioConnect Conference held January 10-13, 2022 Presentation revealed growing need for CGM devices, diabetes market estimated at $150 billion NMRD's sugarBEAT(R) devices measure glucose at the skin surface, non-invasive, easy to use NMRD recently commenced product shipments in lieu of an order for 5,000 CGM devices and 200,000 sensors to UK licensing partner MySugarWatch Limited NMRD recently announced launch of Miboko metabolic health program targeted at global employers and insurers Dr. Faz Chowdhury, CEO of Nemaura Medical (NASDAQ: NMRD), recently presented at the H.C. Wainwright BioConnect Conference on January 10-13, 2022,…

MondayFeb 14, 2022 9:15 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Receives IRB Approval for Kernel Flow Feasibility Study

Institution Review Board gives green light to study designed around Kernel’s quantitative neuroimaging technology Kernel Flow device provides ability to measure longitudinal brain activity before, during and after a psychedelic experience CYBN CEO says results from study will further support company’s mission to develop psychedelics into therapeutics Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), has received approval to move forward on a key feasibility study designed to measure ketamine’s psychedelic effect on cerebral cortex hemodynamics (https://ibn.fm/f0HXk). The approval, granted by the Institution Review Board (“IRB”), gives a green light to a Cybin-sponsored study…

FridayFeb 11, 2022 9:30 am

New York Eases Access to Medical Marijuana

Earlier this year, the state of New York gave permission to physicians to prescribe medical marijuana for a myriad of conditions. These changes represent a huge shift in the state’s medical cannabis program, which was at one point among the most restrictive in the country. The state is focused on establishing its legal recreational marijuana market, with its Office of Cannabis Management allowing dispensaries to begin selling whole cannabis buds for smoking, expanding ranks of providers and proposing rules for patients who would like to cultivate their own cannabis. Many expect the state’s soon-to-be established adult-use marijuana market to become…

ThursdayFeb 10, 2022 9:30 am

What You Should Know about Seasonal Depression

Seasonal depression, or seasonal affective disorder, is a form of depression that occurs at a similar time every year. It typically comes during the winter and fall seasons, which is why it is important to be aware of correlated mental health conditions as winter rages on. Estimates show that roughly 5% of individuals in the United States are affected by seasonal depression, with data from U Health also showing that about 14% of adults in the country are impacted by milder versions of seasonal depression as well as other mood disorders. Chief of the Adult Psychiatry Division at the University…

WednesdayFeb 09, 2022 9:30 am

Diabetes Fatalities in US Top 100,000 for Second Consecutive Year

Diabetes was the seventh-leading cause of death in the United States in 2019, claiming the lives of more than 87,000 individuals. However, recently publicized data shows that more than 100,000 individuals in the U.S. succumbed to diabetes last year. These new figures come as the National Clinical Care Commission calls for Congress to improve diabetes care and prevention, having given recommendations to stop relying solely on medical interventions. A report that was released last month urges that broader policy changes be made in an effort to contain the diabetes epidemic. These changes include expanding access to affordable housing, imposing taxes…